Ad is loading...
MENU
MRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Marinus Pharmaceuticals (MRNS) Ownership - Who owns Marinus Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.79M
P/E Ratio
N/A
Total Cash
42.18M
Projected Growth
N/A
Total Debt
55.99M
Revenue
31.47M
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash/Share
0.76
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price

Fundamentals

MRNS
Capitalization
17.8M
P/E Ratio
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash
42.2M
Total Cash/Share
0.76
Total Debt
56M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.55%
Revenue
31.5M
ROE
N/A
Book Value
-66.74M
P/B Ratio
4.36
Cash Flow
N/A
Earnings
-2.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
1.66
Current Revenue Per Employee
51451.81
Dividends Per Share - Security
N/A
EBITDA
-122.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.64
Revenue To Assets
-106.26
Shares Held By Institutions
73.2M
Shares Outstanding - Current
55.2M
Total Liabilities
130M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-97.035
View a ticker or compare two or three
MRNS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com